Abstract
The vessels of the head are sensitive to bradykinin If we inject small doses of this substance intravenously, a transient flush in the face, but not in other parts of the body, is observed. The circulation of the facial skin is more sensitive to bradykinin than other areas of skin are to vasodilating agents. The intracranial extracerebral vasculature also responds quickly to an administration of the polypeptide, but this is demonstrable only with the aid of special techniques. The circulation of the brain seems to be scarcely influenced by polypeptides.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Allwood, M. J., Lewis, G. P.: Bradykinin in human blood during vasodilation. J. Physiol. (Lond.) 166, 47P (1963).
Allwood, M. J., Lewis, G. P.: Bradykinin and forearm blood flow. J. Physiol. (Lond.) 170, 571 (1964).
Amundsen, E., Rugstad, H. E.: Influence of some pathogenic bacteria on kinin formation and destruction. Brit. J. Pharmacol. 25, 67 (1965).
Antony, M., Hinterrerger, H., Lance, J. W.: Plasma serotonin in migraine and stress. Arch. Neurol. (Chic.) 16, 544 (1967).
Arcangeli, P., Galletti, R.: La cefalea da istamina. Rass. Neurol. veg. 10, 109 (1953).
Armstrong, D., Jepson, J. B., Keele, C. A., Stewart, J. W.: Pain producing substance in human inflammatory exudates and plasma. J. Physiol. (Lond.) 135, 350 (1957).
Armstrong, D., Mills, G. L., Sicuteri, F.: Physiological influence on the liberation of human plasma kinin at low temperature. In: Hypotensive peptides, p. 139, ed. by E. G. Erdös, N. Back and F. Sicuteri. Berlin-Heidelberg-New York: Springer 1966.
Astrup, T., Permin, P. M.: Fibrinolysis in the animal organism. Nature (Lond.) 159, 681 (1947).
Atkins, E., Hijn, C., Jr.: Studies on tubercolin fever. III. Mechanism involved in the release of endogenous pyrogen in vitro. J. exp. Med. 122, 207 (1965).
Back, N.: In vivo formation of a vasodilator substance by plasmin. Fed. Proc. 19, 55 (1960).
Back, N., Wilkens, H., Steger, R.: Fibrinolysis and vasoactive peptides in anaphylaxis In: Hypotensive peptides, p. 485, ed. by E. G. Erdös, N. Back and F. Sicuteri. BerlinHeidelberg-New York: Springer 1966.
Bavazzano, A., Del Bene, E., Anselmi, B., Sicuteri, F.: Kinin release by lysosomal labilization in man. Rass. Neurol. Veg. 1, 56 (1968).
Bavazzano, A., Fanciullacci, M., Sicuteri, F.: Effetto delle endotossine in dosi subfebbrili su alcuni livelli plasmatici enzimatici (beta-glucuronidasi, fosfatasi) e sulla diuresi nell’uomo. Boll. Soc. ital. Biol. sper. 43, 1403 (1967).
Becker, E. L., Kagen, L.: The permeability globulins of human serum and the biochemical mechanism of hereditary angioneurotic edema. Ann. N.Y. Acad. Sci. 116, 866 (1964).
Beretta, A. A., Feruglio, F. S., Campus, S., Chiandussi, L., Pandolfo, G., Bert, G.: The effect of eledoisin and bradykinin in the general and visceral circulation. In: Hypotensive peptides, p. 430, ed. by E. G. Erdös, N. Back and F. Sicuteri. Berlin-HeidelbergNew York: Springer 1966.
Bertaccini, G., Cei, J. M., Erspamer, V.: The action of physalaemin on the systemic arterial blood pressure of some experimental animals. Brit. J. Pharmacol. 25, 380 (1965).
Bertelli, A., Proro, M., Rossano, M. A.: Azione inibente dell’acido epsilon aminocaproico sui fenomeni essudativi ed infiammatori. Atti Accad. med. lombarda 17, 204 (1962).
Bertolini, A., Castelli, M, Mucci, P, Sternieri, E: Relationship between behavioural effect and circulatory changes produced by intra-carotid bradykinin. Proceedings, Internat Symposium on the Pharmacology of Hormonal Polypeptides and Proteins. Milan, Sept. 1968. New York: Plenum Publ. Corpor. 1968.
Bertolini, A., Mucci, P., Ferrari, W.: La bradichinina come possibile agente causale dell’ emicrania. III. Effetto dell’iniezione endocisternale di bradichinina nel cane e nel coniglio. Boll. Soc. ital. Biol. sper. 42, 1922 (1966).
Bertolini, A., Sternieri, E.: La bradichinina come possibile agente causale dell’ emicrania. IV. Rapporto tra gli effetti comportamentali e circolatorio della bradichinina, iniettata per via endocarotidea nel coniglio. Boll. Soc. ital. Biol. sper. 43, 794 (1967).
Bobbin, R. P., Guth, P. S.: Venoconstrictive action of bradykinin J Pharmacol. exp. Ther. 160, 11 (1967).
Bovet, E., Carpi, A., Virno, M.: Pharmacodynamie de la circulation cérébrale. Experientia (Basel) 16, 1 (1960).
Bovet, E., Sicuteri, F.: Vasomotricité cérébrale et allergie. Physiopatologie de la céphalée provoquée par l’histamine. Relazione, 3d Congr. Europeo di Allergologia, vol. II. Rome: Pensiero Scientifico 1956.
Braun, C., Guzman, F., Horton, E. W., Lim, E. K. S., Potter, G. D.: Visceral receptors, pain, bradykinin and analgesic agents. J. Physiol. (Lond.) 155, 13 (1961).
Breda, G., Concioli, M., Mariani, L.: Shock anafilattico e bradichinina: Confronto tra le modificazioni del circolo corticopiale della cavia. Atti Accad. med. lombarda 17, 335 (1962).
Buckley, J. P., Bickerton, R. K., Halliday, R. P., Kato, H.: Central effects of peptides on the cardiovascular system. Ann. N.Y. Acad. Sci. 104, 299 (1963).
Capek, R.: Some effects of bradykinin on the central systems. Biochem. Pharmacol. 10, 61 (1961).
Cardoso, S. S., Amorin, O. S., Nogueira, A. D., Alencar, J. A., Corrado, A. P., Rego, S. M.: Bradykinin induced leukocytosis in man and in dogs. Proceedings, Internat. Symposium on Vaso-Active Polypeptides, p. 263, ed. by M. Rocha E Silva and H. A. Rothschild. Sao Paulo 1967.
Carpi, A., Corrado, A. P.: Cerebral vascular action of bradykinin in the dog. Experientia (Basel) 17, 326 (1961).
Chapman, L. F., Ramos, A. O., Corrado, A. P., Fortes, V.: Release of proteolytic enzymes from cat brain during stimulation. Arch. Neurol. (Chic.) 3, 43 (1960a).
Chapman, L. F., Goodell, H., Silverman, G., Wolff, H. G.: A humoral agent implicated in vascular headache of the migraine type. Arch. Neurol. (Chic.) 3, 223 (1960b).
Chapman, L. F., Wolff, H. G.: Studies of proteolytic enzymes in cerebrospinal fluid. Arch. intern. Med. 103, 86 (1959).
Clarke, J. M.: On recurrent motor paralysis in migraine: With report of a family in which recurrent hemiplegia accompanied the attacks. Brit. med. J. 1910 I, 1534.
Cline, M. J., Melmon, K. L.: The effect of cortisol on the plasma kinin system. Proceedings, Internat. Symposium on Vaso-Active Polypeptides, p. 247, ed. by M. Rocha E Silva and H. A. Rothschild. Sao Paulo 1967.
Cohx, Z. A., Hirsch, J. G.: The isolation and properties of the specific cytoplasmic granules of rabbit polymorphonuclear leucocytes. J. exp. Med. 112, 983 (1960).
Collier, H. O. J., Shorley, P. G.: Analgesic antipyretic drugs as antagonists of bradykinin. Brit. J. Pharmacol. 15, 601 (1960).
Concioli, M., Santandrea, E., Villani, R.: Modificazioni del circolo piale sotto l’influsso di particolari stimoli e soprattutto della bradichinina. Rilievi microcinematografici. Atti Accad. med. lombarda 16, 268 (1961).
Cooper, K. E., Cranston, W. I., Honour, M. R. C.: The site of action of leucocyte pyrogen in the rabbit brain. J. Physiol. (Lond.) 18, 1 (1966).
Coppen, A. J., Lewis, G. P.: An enzyme forming vasodilator polypeptides in human cerebrospinal fluid. J. Neurochem. 7, 155 (1961).
Corrado, A. P.: Recent investigations of the pharmacology of bradykinin and their physiopathological implications. In: Bradykinin and its precursor, ed. by F. Sicuteri. Settim. med. Suppl., 45, 30 (1963).
Corrado, A. P., Ramos, A. O., Rocha E Silva, M.: Possiveis acoes centrais da bradicinina. Ciencia e Cultura 11, 165 (1959).
Dalessio, D. J., Camp, W. A., Goodell, H., Wolff, H. G.: Studies on headache. The mode of action of UML-491 and its relevance to the nature of vascular headache of the migraine type. Arch. Neurol. (Chic.) 4, 235 (1961).
De Duve, C.: Lysosomes: A new group of cytoplasmic particles. In: Subcellular particles, p. 128, ed. by T. Hayashi. New York: Ronald Press Co. 1959.
De Duve, C., Vattiaux, R.: Function of lysosomes. Ann. Rev. Physiol. 28, 435 (1966).
Dessy, P., Uslenghi, E., Cagna, C., Accatino, G., Betti, C.: Azione della bradichinina sun’ emodinamica generale e distrettuale. Circolo cerebrale. Minerva med. 57, 3555 (1966).
Diniz, C. R., Carvalho, L. F., Dos Reis, M. L., Corrado, A. P.: Bradykininogen in some experimental conditions. Proceedings, Internat. Symposium on Vaso-Active Polypeptides, p. 15, ed. by M. Rocha E Silva and H. A. Rothschild Sao Paulo 1967.
Diniz, C. R., Rocha E Silva, M.: A micromethod for the determination of bradykininogen in the blood plasma. Nature (Lond.) 192, 1194 (1961).
Doeifner, W., Cerletti, A.: Comparison of lysergic acid derivates and antihistamines as inhibitor of the edema provoked in the rat’s paw by serotonin. Int. Arch. Allergy 12, 89 (1958).
Eisen, V., Keele, C. A.: Possible modes of kinin formation in some pathological states in man. In: Hypotensive peptides, p. 551, ed. by E. G. Erdös, N. Back and F. Sicuterl Berlin-Heidelberg-New York: Springer 1966.
Ekbom, K. A.: Treatment of migraine, Horton’s syndrome and restless legs with Deseril (UML-491). Acta neurol. scand. 38, 313 (1962).
Elder, J. M., Wilhelm, D L: Enzyme-like globulins from serum reproducing the vascular phenomena of inflammation. V. Activable permeability factor in human serum. Brit. J. exp. Path. 39, 23 (1958).
Erdös, E. G.: Hypotensive peptides. Bradykinin, kallidin and eledoisin. Advanc. Pharmacol. 4, 1 (1966).
Erdös, E. G., Sloane, E. M.: An enzyme in human blood plasma that inactivates bradykinin and kallidin. Biochem. Pharmacol. 11, 585 (1962).
Erdös, E. G., Wohler, J. R.: Inhibitors of the in vivo effects of bradykinin and kallidin. Life Sci. 2, 270 (1963).
Erdös, E. G., Levine, M. I.: Blocking of the in vivo effects of bradykinin with carboxypeptidase B. J. Pharmacol. exp. Ther. 142, 327 (1963).
Erspamer, V.: Pharmacologically active substances of mammalian origin. Ann. Rev. Pharmacol. 1, 175 (1961).
Erspamer, V., Anastasi, A.: Structure and pharmacological actions of eledoisin, the active endecapeptide of the posterior glands of eledone. Experientia (Basel) 18, 58 (1962).
Erspamer, V., Bertaccini, G., Cei, J. M.: Structure and pharmacological actions of physalaemin, the main active polypeptides of the skin of Physalaemus fuscumaculatus. Experientia (Basel) 20, 489 (1964).
Erspamer, V., Glasser, A.: The action of eledoisin on the systemic arterial blood pressure of some experimental animals. Brit. J. Pharmacol. 20, 516 (1963).
Fishman, W. H., Springer, B., Brunetti, R.: Application of an improved glucuronidase assay method to the study of human blood beta-glucuronidase. J. biol. Chem. 173, 449 (1948).
Friedmann, A. P., Elkind, A.: Appraisal of methysergide in treatment of vascular headache of migraine type. J. Amer. med. Ass. 184, 125 (1961).
Gelfand, M. D., West, G. B.: Experimental studies with the butanolamide and propanol-amide of 1-methyl-lysergic acid. Int. Arch. Allergy 18, 288 (1961).
Gilfoil, T. M., Klavins, I.: 5-Hydroxytryptamine, bradykinin and histamine as mediators of inflammatory hyperesthesia. Amer. J. Physiol. 208, 867 (1965).
Goodwin, L. G., Boreham, P. F. L.: Pharmacologically active peptides in trypanosome infections. In: Hypotensive peptides, p. 545, ed. by E. G. Erdös, N. Back and F. Sicuteri. Berlin-Heidelberg-New York: Springer 1966.
Graeff, F. G., Corrado, A. P., Pela, J. P., Capek, R.: Actions of bradykinin upon the central nervous system. Proceedings, Internat. Symposium on Vaso-Active Polypeptides, p. 97, ed. by M. Rocha E Silva and H. A. Rothschild Sao Paulo 1967.
Graeff, F. G., Ferreira, S. H., Corrado, A. P., Rocha E Silva, M.: Potentiation of the cerebral vascular action of bradykinin by the bradykinin potentiating factor (BPF) in the dog. Experientia (Basel) 21, 607 (1965).
Greenbaum, L. M., Kim, K. S.: The kinin-forming and kininase activities of rabbit polymorphonuclear leucocytes. Brit. J. Pharmacol. 29, 372 (1967).
Greenbaum, L. M., Yamafuji, K., Kim, K. S.: Studies on the kinin-forming and inactivating enzymes in tissue and leucocytes. Proceedings, Internat. Symposium on Vaso-Active Polypeptides, p. 21, ed. by M. Rocha E Silva and H. A. Rothschild Sao Paulo 1967.
Greppi, E., Martinetti, R.: Le cefalee. Proceedings, 49th Congr. Ital. Soc. of Internal Medicine. Rome: Pozzi 1948.
Greppi, E., Sicuteri, F.: L’Emicrania-motivi di fisiopatogenesi e di terapia. Proceedings, 65th Congr. Ital. Soc. of Internal Medicine. Rome: Pozzi 1964.
Haefely, W., Hurlimann, A., Thoenen, H.: The effects of bradykinin and angiotensin on ganglionic transmission. In: Hypotensive peptides, p. 314, ed. by E. G. Erdös, N. Back and F. Sicuteri. Berlin-Heidelberg-New York: Springer 1966.
Hilton, S. M., Schain, R. J.: A search for pharmacologically active substances in fluid from the cerebral ventricles. J. Physiol. (Lond.) 157, 46P (1961).
Horton, E. W.: An increase in butanol-extractable 5-hydroxytryptamine in venous blood during reactive hyperemia. J. Physiol. (Lond.) 170, 101 (1964).
Janoff, A., Schaeffer, S.: Mediators of acute inflammation in leucocyte lysosomes. Nature (Lond.) 214, 144 (1967).
Jelliffe, S. E.: Aphasia, hemiparesis and hemianaesthesia in migraine. N.Y. St. Med. J. 83, 33 (1906).
Kappas, A., Hellman, L., Fukushima, D. K., Gallagher, T. F.: The pyrogenic effect of ethiocolanone (3-d-hydroxyetiocholane-17-one). J. clin. Endocr. 16, 948 (1956).
Keele, C. A., Armstrong, D.: Mediators of pain. In: Pharmacology of pain, vol. 9, p. 3, ed. by Lue, Armstrong and Prado. Oxford: Pergamon Press 1968.
Kety, S. S., Schmidt, C. F.: Nitrous oxide method for the quantitative determination of cerebral blood flow in man: Theory, procedure and normal values. J. clin. Invest. 27, 476 (1948).
Krivoy, W. A., Lane, M., Kroeger, D. C.: The actions of certain polypeptides on synaptic transmission. Ann. N.Y. Acad. Sci. 104, 312 (1963).
Kwaan, H. C., Mcfadzean, A. J. C.: On plasma fibrinolytic activity induced by ischemia. Clin. Sci. 16, 245 (1956).
Lance, J. W., Anthony, M., Hinterberger, H.: The control of cranial arteries by humoral mechanisms and its relation to the migraine syndrome. Headache 7, 93 (1967).
Landerman, N. S., Webster, M. E., Becker, E. L., Ratcliffe, H. E.: Hereditary angioneurotic edema. II. Deficiency of inhibitor for serum globulin permeability factor and/or plasma kallikrein. J. Allergy 33, 330 (1960).
Lewis, G.: In: Proceedings, First Internat. Pharmacol. Meeting, vol. 9, p. 65, ed. by M. Rocha E Silva and U. S. Von Euler. Oxford: Pergamon Press 1963.
Lim, R. K. S., Miller, D. G., Gurman, F., Rodgers, D. W., Rodgers, R. W., Wang, S. K., Chao, P. Y., Shin, T. Y.: Pain and analgesia evaluated by the intraperitoneal bradykinin evoked pain method in man. Clin. Pharmacol. Ther. 8, 521 (1967).
Lunedei, A.: Sulle flogosi fronto-basilari iperergiche. Rev. clin. Med. 48, 81 (1948).
Lunedei, A., Serafini, V., Arcangeli, P., Noferi, G., Pratesi, F., Doni, A., Milano, M.: Apoplessia cerebrale. Il problema etiopatogenetico. Proceedings, 58th Congr. Ital. Med. Soc. Rome: Pozzi 1957.
Mackay, M. E., Miles, A. A., Schachter, C. B. E., Wilhelm, D L: Susceptibility of the guinea pig to pharmacological factors from its own serum. Nature (Lond.) 172, 714 (1953).
Mashford, M. L., Zacest, R.: Effect of adrenaline on blood kininase activity in man. Suppl. III, Circulat. Res. 20 /21, 183 (1967).
Melmon, K. L., Cline, M J: Kinins and granulocytes: Model of inflammation. Proceedings, Internat. Symposium on Vaso-Active Polypeptides, p. 223, ed. by M. Rocha E Silva and H. A. Rothschild. Sao Paulo 1967.
Miles, A. A.: Local and systemic factors in shock. Fed. Proc. 20, 1941 (1961).
Miles, A. A., Wilhelm, D L: Enzyme-like globulins from serum reproducing the vascular phenomena of inflammation. An activable permeability factor and its inhibitor in guinea-pig serum. Brit. J. exp. Path. 36, 71 (1955).
Oates, J. A., Melmon, K. L.: Biochemical and physiological studies of kinins in carcinoid syndrome. In: Hypotensive peptides, p. 565, ed. by E. G. Erdös, N. Back and F. Sicuteri. Berlin-Heidelberg-New York: Springer 1966.
Palmer, R. H., Ratkovits, B., Kappas, A.: Steroid pyrogen studies in laboratory domestic animals. J. appl. Physiol. 16, 345 (1961).
Pekkarinen, A., Castren, O., Iisalo, E., Koivusalo, M., Laihinena, Simola, P. E., Thomasson, B.: The emotional effect of matriculation examinations on the excretion of adrenaline, noradrenaline, 17-hydroxycorticosteroids into the urine and the content of 17-hydroxycorticosteroids in the plasma. Biochemistry, pharmacology and physiology, p. 117. Oxford: Pergamon Press 1961.
Periti, P., Comparini, A., Sicuteri, F.: Bradichinogeno in corso di malattie infettive acute. Boll. Soc. ital. Biol. sper. 39, 327 (1963a).
Periti, P., Michelacci, S., Santini, D.: Plasmachinine libere nel sangue umano. Boll. Soc. ital. Biol. sper. 39, 307 (1963b).
Periti, P., Sicuteri, F., Franchi, G., Michelacci, S.: Azione dell’istamino-liberatore 48/80 sul bradichinogeno e plasmachinine del sangue venoso dopo somministrazione endovenosa ed endoarteriosa. Boll. Soc. ital. Biol. sper. 40, 951 (1964).
Pickering, G. W.: Experimental observations on headache. Brit. med. J. 1939 I, 4087.
Pickering, G. W., Hess, W.: Observations on the mechanism of headache produced by histamine. Clin. Sci. 1, 77 (1933).
Rafter, G. W., Collins, R. D., Wood, W. B.: Studies on the pathogenesis of fever. Preliminary chemical characterization of leucocytic pyrogen. J. exp. Med. 111, 831 (1960).
Rocha E., Silva, M.: Autofarmacologia e venenos animais. Ciencia e Cultura 2, 44 (19501.
Rocha E., Silva, M.: Physiological significance of bradykinin. Ann. N.Y. Acad. Sci. 104, 190 (1963).
Rocha E., Reis, M. L., Ferreira, S. H.: Release of kinins from fresh plasma under varying experimental conditions. Biochem. Pharmacol. 16, 1665 (1967).
Schachter, M.: A delayed slow contracting effect of serum and plasma due to the formation of a substance resembling bradykinin and kallidin. Brit. J. Pharmacol. 11, 111 (1956).
Shimamoto, T., Nimano, F., Ftjita, T., Jshiota, T., Atsumi, T.: Treatment of experimental and human atherosclerosis with bradykinin antagonist, pyridinolcarbamate: A preliminary report. In: Hypotensive peptides, p. 506, ed. by E. G. Erdös, N. Back and F. Sicuteri. Berlin-Heidelberg-New York: Springer 1966.
Sicuteri, F.: Il test liquorale per lo studio della vasomotilita intracranica. Triangle 4, 149 (1959a).
Sicuteri, F.: Prophylactic and therapeutic properties of 1-methyl-lysergic acid butanolamide in migraine. Int. Arch. Allergy 15, 300 (1959b).
Sicuteri, F.: Mast cells and their active substances: Their role in the pathogenesis of migraine. Headache 3, 86 (1963).
Sicuteri, F.: Headache and meningismus evoked by lumbar and subarachnoid hemorrhage. A biochemical interpretation. Headache 5, 108 (1966).
Sicuteri, F.: Vasoneuroactive substances and their implication in vascular pain. In: Research and clinical studies in headache, p. 6, ed. by Friedman. Basel 1967 a.
Sicuteri, F.: Sensitization of nociceptors by 5-hydroxytryptamine in man. In: Proceedings, 3rd Internat. Pharmacol. Congr., p. 57. Oxford 1967 b.
Sicuteri, F.: Treatment of subarachnoid and other intracranial hemorrhages with proteinase inhibitors. In: Chemistry, pharmacology and clinical applications of proteinase inhibitors. Ann. N.Y. Acad. Sci. 146, 682 (1968).
Sicuteri, F., Anselmi, B., Del Bene, E.: Il pirogeno in dosi non febbrigene come test rivelatore di flogosi croniche intracraniche. Rif. med. 44, 1 (1966a).
Sicuteri, F., Del Bianco, P. L., Fanciullacci, M., Franchi, G.: Il test della venocostrizione per la misura della sensibilita alla 5-idrossitriptamina e alle catecolamine nell’uomo. Boll. Soc. ital. Biol. sper. 40, 1148 (1964a).
Sicuteri, F., Fanciullacci, M., Bavazzano, A., Franchi, G.: Influenza di un inibitore della callicreina sulla fenomenologia da emorragia intracranica sperimentale. Boll. Soc. ital. Biol. sper. 43, 1061 (1967a).
Sicuteri, F., Del Bianco, P. L.: Vasoattivitâ dell’endecapeptide fisalemina nell’uomo. Settim. med. 52, 1221 (1964b).
Sicuteri, F., Franchi, G., Del Bianco, P. L.: Serotonin-bradykinin potentiation on the pain receptors in man. Life Sci. 4, 309 (1965a).
Sicuteri, F., Franchi, G., Del Bianco, P. L., Michelacci, S.: The endecapeptide eledoisin as powerful vasodilating and hypotensive agent in man. Experientia (Basel) 19, 44 (1963d).
Sicuteri, F., Franchi, G., Del Bianco, P. L.: Un test per lo studio dell’azione dolorifica della bradi-chinina nell’animale: Il fenomeno grido-fuga del coniglio. Boll. Soc. ital. Biol. sper. 42, 845 (1966b).
Sicuteri, F., Franchi, G., Del Bianco, P. L.: An antiaminic drug, BC-105, in the prophylaxis of migraine. Int. Arch. Allergy 31, 78 (1967c).
Sicuteri, F., Fanciullacci, M.: Peptides and pain. Proceedings, Internat. Symposium on Vaso-Active Polypeptides, p. 251, ed. by M. Rocha E Silva and H. A. Rothschild Sao Paulo 1967 b.
Sicuteri, F., Fanciullacci, M., Del Bianco, P. L., Siddel, N.: Adrenergic receptors and kinins. In: Pharmacology of hormonal polypeptides and proteins, p. 601. Ed. by N. Back, L. Martini and R. Paoletti. New York: Plenum Press 1968.
Sicuteri, F., Michelacci, S.: Prime osservazioni sull’effetto della bradichinina sul circolo cerebrale nell’uomo. Settim. med. 49, 7 (1961b).
Sicuteri, F., Periti, P.: Physiopathological aspects of bradykinin and its precursor in man. In: Bradykinin and its precursor, p. 53, ed. by F. Sicuteri. Rome: Publ. C.E.P.I. 1963 a.
Sicuteri, F., Michelacci, S., Anselmi, B.: Termination of migraine headache by a new anti-inflammatory vasoconstrictor agent. Clin. Pharmacol. Ther. 6, 336 (1965b).
Sicuteri, F., Periti, P., Anselmi, B., Fanciullacci, M.: Livelli plasmachininici nell’uomo dopo somministrazione venosa ed endoarteriosa di bradichinina sintetica e naturale. Boll. Soc. ital. Biol. sper. 39, 314 (1963c).
Sicuteri, F., Franchi, G.: Bradichininogeno e chinine libere nel liquido cefalorachidiano dell’uomo. Boll. Soc. ital. Biol. sper. 40, 67 (1963b).
Sicuteri, F., Periti, P., Gasparri, F., Franchi, G., Fanciullacci, M.: Diminuzione del tasso ematico di bradichininogeno nell’uomo dopo somministrazione di adrenalina e callicreina. Boll. Soc. ital. Biol. sper. 38, 1033 (1962).
Sicuteri, F., Ricci, M., Monfariini, R., Ficini, M.: Cefalea sperimentale da istamina endogena. Settim. med. 44, 583 (1956).
Sicuteri, F., Testi, A., Anselmi, B.: Biochemical investigations in headache: Increase in the hydroxyindoleacetic acid during migraine attacks. Int. Arch. Allergy 19, 55 (1961a).
Sternieri, E., Mucci, P., Bertolini, A.: Modificazioni indotte farmacologicamente dalla risposta del circolo cerebrale alla bradichinina. 1. Rapporto tra vocalizzazione ed aumento del sangue nel territorio cerebrale. Boll. Soc. ital. Biol. sper. 43, 1196 (1967).
Sutherland, A. M., Wolff, H. G.: Experimental studies on headache: Further analysis of the mechanism of headache in migraine, hypertension and fever. Arch. Neurol. Psychiat. (Chic.) 44, 929 (1940).
Trautschold, I., Fritz, H., Werle, E.: Kininogenases, kininases and their inhibitors. In: Hypotensive peptides, p. 221, ed. by E. G. Erdös, N. Back and F. Sicuteri. Berlin-Heidelberg-New York: Springer 1966.
Tunis, M. M., Goodell, H., Wolff, H. G.: Studies on headache: Evidence of tissue damage and changes in pain sensitivity in subjects with vascular headache of the migraine type. Trans. Ass. Amer. Phycns 66, 332 (1953).
Virno, M., Gertner, S. B., Bovet, D.: Action of histamine on the jugular venous pressure and cerebral circulation of the dog. Effects of antihistaminic drugs (pyrilamine and chlorpheniramine) and histamine liberating agent (48/80 B.W.). J. Pharmacol. exp. Ther. 118, 63 (1956).
Vogt, W.: Kinin formation by plasmin, an indirect process mediated by activation of kallikrein J. Physiol. (Lond.) 170, 153 (1964).
Webster, M. E., Innerfield, I.: Interrelationship of human plasma kallikrein and plasmin in inflammation. Enzymol. biol. clin. 5, 129 (1965).
Weissmann, G.: Labilization and stabilization of lysosomes. Fed. Proc. 23, 1038 (1964).
Weissmann, G.: Lysosomes. New Engl. J. Med. 11, 1084 (1965).
Weissmann, G., Lewis, G. P.: Studies on lysosomes. The effect of endotoxin tolerance and cortisone on the release of hydrolases from a granular fraction of rabbit liver. J. exp. Med. 116, 433 (1962).
Weissmann, G., Thomas, L.: On a mechanism of tissue damage by bacterial endotoxin. In: Bacterial endotoxins, ed. by M. Landy and W. Braun. New Brunswick: Rutgers University Press 1964.
Werle, E., Trautschold, I.: Kallikrein, kallidin, kallikrein inhibitors. Ann. N.Y. Acad. Sci. 104, 117 (1963).
Whitty, C. W. H.: Familial hemiplegic migraine. J. Neurol. Neurosurg. Psychiat. 16, 172 (1953).
Wolff, H. G.: Headache and cranial arteries. Trans. Ass. Amer. Phycns 58, 193 (1938).
Wolff, H. G.: Headache and other head pain. Oxford: Univ. Press 1963.
Wolff, H. G., Tuxes, M. M.: Analysis of cranial artery pressure pulse waves in patients with vascular headache of the migraine type. Trans. Ass. Amer. Phycns 65, 240 (1952).
Wood, W. B., Jr.: The role of endogenous pyrogen in the genesis of fever. Lancet 1958 II, 53.
Zetler, G., Lembeck, F.: Substance P, a polypeptide of possible physiological importance, especially for the Central nervous system. Int. Rev. Neurobiol. 4, 159 (1962).
Zweifach, B. W.: Microcirculatory effects of polypeptides. In: Hypotensive peptides, p. 451, ed. by E. G. Erdös, N. Back and F. Sicuteri. Berlin-Heidelberg-New York: Springer 1966.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1970 Springer-Verlag Berlin · Heidelberg
About this chapter
Cite this chapter
Sicuteri, F. (1970). Bradykinin and Intracranial Circulation in Man. In: Erdös, E.G., Wilde, A.F. (eds) Bradykinin, Kallidin and Kallikrein. Handbook of Experimental Pharmacology / Handbuch der experimentellen Pharmakologie, vol 25 / 25. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-46222-1_23
Download citation
DOI: https://doi.org/10.1007/978-3-642-46222-1_23
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-46224-5
Online ISBN: 978-3-642-46222-1
eBook Packages: Springer Book Archive